Caco-2 Monolayer assays

Monolayers based on Caco-2 cells (a human colon carcinoma cell line) express a wide range of transporter proteins on its cell membranes similar to those of intestinal endothelium cells (Siissalo S et al. 2007, Calcagno AM et al. 2006), thus this cell line is ideal for intestinal absorption simulations. In fact, in the last decade, the utilization of Caco-2 cells has become an industry standard for the investigation of intestinal absorption, permeability and drug-drug interactions (DDIs) (Oh DM et al. 2002.).

SOLVO Biotechnology offers Caco-2 studies as part of its PrediScreen service solutions. Three types of studies are available:

  1. Passive permeability studies
  2. Specific transporter studies
  3. Drug-Drug Interaction studies

Caco-2 studies can be performed in different setups. SOLVO offers a number of standard setups, which differ in the amount of information derived and cost. These standard setups serve as starting points to define the optimal final study parameters.

The following standard setups are available:

1. Basic - Studies at one concentration
2. Extended- Studies at several concentrations, more controls
3. FDA Guidelines- Studies according to FDA draft guidance (2006)

These packages can be customized to suite your needs. The following table summarizes some adjustable parameters.

ParameterOptionEffect on price
UnidirectionalA-B or B-Adepends on nr of wells
Nr of parallelsDuplicates or moredepends on nr of wells
TA concentrationno limitationsno effect on price
Nr of TA concentrationsno limitationsdepends on nr of wells
Sink conditions+ 1% BSA in receptor compartmentno effect on price
Nr of samples takenTime points and compartmentsno effect on price (if nr of samples <150)
Specific inhibitorsMore or other inhibitors per transporterdepends on nr of wells


For more details on the Caco2 Monolayer assays please click here







* IC50 determination for inhibition of digoxin transport is also available.

This page contains information about following topics: Caco-2 cells,Monolayer assay,Passive permeability studies,Specific transporter studies,Drug-drug interaction studies,FDA guideline,FDA compliant study,Definitive assay,Digoxin inhibition,P-gp substrate,Intestine Transporter, Pgp assay, Patented cell line, In vitro Transporter Assay, In vivo Transporter interaction, Ex vivo Transporter interaction.